Phibro Animal Health | PAHC - 普通股股本

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.57B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	普通股股本	更改		日
Align Technology	USD 71.62M		1000	2026-06
ANI Pharmaceuticals	USD 22.49M		760K	2025-12
Aurora Cannabis	CAD 58.95M		2.24M	2026-03
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Canopy Growth	CAD 422.07M		53.78M	2026-03
Corcept Therapeutics	USD 107.33M		1.36M	2026-03
Eli Lilly	USD 943.5M		3.33M	2026-03
Henry Schein	USD 111.92M		2.51M	2026-06
Idexx Laboratories	USD 78.87M		366K	2026-06
Knight Therapeutics	CAD 99.68M		24.66K	2025-09
Merck	USD 2.47B		4.93M	2026-03
Nektar Therapeutics	USD 29.47M		9.09M	2026-03
Pacira	USD 39.82M		512K	2026-06
Phibro Animal Health	USD 40.48M		0	2025-12
Prestige Brands	USD 47.37M		53K	2026-06
Supernus Pharmaceuticals	USD 58.16M		124K	2026-06
Zoetis	USD 414.15M		6.19M	2026-06